Bionomics
is in an ongoing phase prevail study for acute social anxiety disorder compelling rationale for as an acute treatment in social anxiety disorder behavioral task | Bionomics
Company
Deck date
June 2022
Slide
8 of 16
Similar slides by Bionomics
Investor Presentation
October 2022
Related slides by other companies
Investor Presentation
September 2023
Investor Presentation
October 2022
Investor Presentation
June 2020
Investor Presentation
November 2022
Other recent decks by Bionomics
Results
March 2023
Investor Presentation
October 2022
Investor Presentation
April 2022
IPO
December 2021
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io